The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
Speakers' Bureau - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
Is the BRAF mutation still an unfavorable risk factor in patients with metastatic melanoma in the era of modern therapies?
 
Bozena Cybulska-Stopa
Honoraria - MSD; Novartis; Pierre Fabre
Consulting or Advisory Role - MSD
Speakers' Bureau - MSD; Novartis; Pierre Fabre
 
Anna Malgorzata Czarnecka
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Novartis; Pierre Fabre
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis; Novartis; Pierre Fabre
Speakers' Bureau - Bristol-Myers Squibb; MSD; Novartis; Novartis; Pierre Fabre
 
Krzysztof Ostaszewski
No Relationships to Disclose
 
Karolina Piejko
No Relationships to Disclose
 
Marcin Zietek
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
Speakers' Bureau - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
 
Robert Dziura
No Relationships to Disclose
 
Ewa Rutkowska
No Relationships to Disclose
 
Łukasz Galus
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
Speakers' Bureau - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
 
Jacek Calik
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
Speakers' Bureau - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
 
Agata Sałek-Zań
No Relationships to Disclose
 
Tomasz Zemelka
No Relationships to Disclose
 
Agnieszka Kamycka
No Relationships to Disclose
 
Wieslaw Bal
Honoraria - Bristol-Myers Squibb; Novartis
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis
Speakers' Bureau - Bristol-Myers Squibb; Novartis
 
Tomasz Kubiatowski
No Relationships to Disclose
 
Pawel Rogala
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
Speakers' Bureau - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
 
Tomasz Switaj
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
Speakers' Bureau - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
 
Grazyna Kaminska-Winciorek
Consulting or Advisory Role - Recordati
Speakers' Bureau - Novartis; Sanofi
Travel, Accommodations, Expenses - Pierre Fabre
 
Rafał Suwiński
Honoraria - Bristol-Myers Squibb; MSD
Speakers' Bureau - Bristol-Myers Squibb; MSD
 
Jacek Mackiewicz
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Pierre Fabre
Speakers' Bureau - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
 
Piotr Rutkowski
Honoraria - Bristol-Myers Squibb; Merck; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi
Consulting or Advisory Role - Amgen; Blueprint Medicines; Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
Speakers' Bureau - Novartis; Pfizer; Pierre Fabre
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Orphan Europe; Pierre Fabre